Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel
Uitgebreid zoeken

Amerikaanse aandelen Terug naar discussie overzicht

CELZ (OTC-Markets)

108 Posts
Pagina: «« 1 2 3 4 5 6 »» | Laatste | Omlaag ↓
  3. tonneke 5 april 2019 13:53

    • tonneke

      Lid sinds: 24 sep 2014

      Laatste bezoek: 27 apr 2024

    • Aanbevelingen

      Ontvangen: 410

      Gegeven: 249

    •    Aantal posts: 6.358

    Ik verwacht binnen kort een flinke koersstijging, hoe meer specialisten zich bij CaverStem melden hoe liever ik het heb
  5. tonneke 20 april 2019 22:28

    • tonneke

      Lid sinds: 24 sep 2014

      Laatste bezoek: 27 apr 2024

    • Aanbevelingen

      Ontvangen: 410

      Gegeven: 249

    •    Aantal posts: 6.358


    Celz Management Team...Timothy Warbington
    CEO
    Mr. Warbington has over 25 years of executive level management and ownership experience. Mr. Warbington has been a lifescience investor for over 12 years. Since 2011 he has been the CEO of Creative Medical Health, Inc. and Creative Medical Technology Holdings, Inc., a public company and since 2012, CEO of iBiologics, a spin off from the University of Utah. In connection with this experience, he has built a network of scientists, physicians and executives to participate as executive officers and directors of CMH.

    Donald Dickerson MBA
    CFO
    Mr. Dickerson has a Masters of Business Administration, Finance from the University of Southern California. Mr. Dickerson has worked in a number of management and accounting positions and has experience with companies in the technology, manufacturing and health sciences area. Mr. Dickerson’s experience includes leadership positions at BioRasi, Dell, Boeing Capital and Medistem, Inc.

    Annette Marleau Phd
    Chief Scientific Officer
    Prior to joining CMH, Dr. Marleau was the Director of Tumor Immunology at Aethlon Medical Inc. Dr. Marleau has a PhD in Immunology from the University of Western Ontario as well as a MS in Reproductive Immunology from Ontario Veterinary Collateral, University of Guelph, Canada and a BS in Biology from the University of Waterloo, Canada.

    Thomas Ichim PhD
    President Biotechnology Division
    Dr. Ichim has 20 years experience in the biotechnology industry, having served as the Vice President of Cellular Therapies, Intrexon, Inc. Dr. Ichim is an accomplished inventor and was the President and Chief Scientific Officer at Medistem, Inc., a recently acquired publicly traded company. Dr. Ichim has a PhD in Immunology from University of Sciences Arts and Technology, Olveston Monserrat, a MSc in Microbiology and Immunology from University of Western Ontario, London, Ontario, Canada and a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada. Dr. Ichim has written over 100 peer reviewed publications and has founded and operated successful biotech companies in the past.

    Report TOS
  6. tonneke 20 april 2019 22:40

    • tonneke

      Lid sinds: 24 sep 2014

      Laatste bezoek: 27 apr 2024

    • Aanbevelingen

      Ontvangen: 410

      Gegeven: 249

    •    Aantal posts: 6.358

    Het zijn in ieder geval geen koekenbakkers, heb er het volste vertrouwen in, ik heb alles op CELZ gezet, nog 1 tot 4 jaar en dan een centje extra naast het pensioen
108 Posts
Pagina: «« 1 2 3 4 5 6 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.844
AB InBev 2 5.292
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.552
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.995
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.554
Aedifica 2 832
Aegon 3.257 320.162
AFC Ajax 537 7.020
Affimed NV 2 5.766
ageas 5.843 109.779
Agfa-Gevaert 13 1.865
Ahold 3.536 74.004
Air France - KLM 1.024 34.365
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.775
Alfen 12 16.635
Allfunds Group 3 1.223
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 339
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.768
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.411
AMG 965 126.254
AMS 3 73
Amsterdam Commodities 303 6.524
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.175
Apollo Alternative Assets 1 17
Apple 5 322
Arcadis 251 8.627
Arcelor Mittal 2.024 318.720
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.150
Aroundtown SA 1 183
Arrowhead Research 5 9.288
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.735
ASML 1.762 77.234
ASR Nederland 18 4.133
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.695
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 10 mei

    1. Eurocommercial Q1-cijfers
    2. VK economische groei eerste kwartaal
    3. VK handelsbalans maart
    4. VK industriële productie maart
    5. Wolters Kluwer €1,36 ex-dividend
    6. Aperam €0,50 ex-dividend
    7. AMG €0,20 ex-dividend
    8. Arcadis €0,85 ex-dividend
    9. VS consumentenvertrouwen (Universiteit Michigan) mei (vlp) 77

  2. 13 mei

    1. NL faillissementen april
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht
Naar de hele agenda